Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas W. Smith is active.

Publication


Featured researches published by Thomas W. Smith.


Jacc-cardiovascular Interventions | 2008

Renal Frame Count and Renal Blush Grade: Quantitative Measures That Predict the Success of Renal Stenting in Hypertensive Patients With Renal Artery Stenosis

Ehtisham Mahmud; Thomas W. Smith; Vachaspathi Palakodeti; Owais Zaidi; Lawrence Ang; C. Robinson Mitchell; Nayab Zafar; Guilherme Bromberg-Marin; Shahin Keramati; Sotirios Tsimikas

OBJECTIVESnThis study sought to identify angiographic parameters of favorable clinical response to renal artery stenting.nnnBACKGROUNDnStenting improves blood pressure (BP) control in patients with renal artery stenosis (RAS), but markers predicting a favorable clinical response are limited.nnnMETHODSnRenal perfusion was quantified in hypertensive patients (BP >or=140/90 mm Hg) without RAS by determining renal frame count (RFC) (angiographic frames [30 frames/s] for contrast to reach distal renal parenchyma after initial renal artery opacification) and renal blush grade (RBG) (0: none, 1: minimal, 2: normal, 3: hyperemic parenchymal blush). It was hypothesized that stenting unilateral RAS in hypertensive patients would result in decreased RFC and increased RBG, which might predict BP reduction.nnnRESULTSnThe RFC in 17 consecutive hypertensive patients without RAS (control group) (64.4 +/- 14.2 years, 12 male, 22 kidneys) was 20.1 +/- 5.4, whereas RBG was 2.33 +/- 0.66. In 24 consecutive hypertensive patients with unilateral RAS (study group) (72.7 +/- 11.3 years, 8 male), reduced RFC (26.6 +/- 9.1 to 21.4 +/- 6.7, p < 0.001) and increased RBG (1.63 +/- 0.71 to 2.13 +/- 0.85, p = 0.03) were observed after renal stenting. At 6 months, reduced BP (systolic BP 150.6 +/- 15.6 mm Hg to 128.6 +/- 15.5 mm Hg, p < 0.001; diastolic BP 77.2 +/- 15.6 mm Hg to 68.3 +/- 10.4 mm Hg, p = 0.022) without change in number of hypertensive medications was observed. Clinical responders (systolic BP reduction >15 mm Hg) had a greater decrease in RFC (7.7 +/- 4.6 vs. 1.7 +/- 5.1, p = 0.009) and 78.6% of patients with >4 RFC decrease were responders (p = 0.024).nnnCONCLUSIONSnThis study shows that quantitative indices of renal perfusion (RFC and RBG) are impaired in patients with RAS and improve after stenting, and that RFC reduction is associated with BP reduction.


Jacc-cardiovascular Interventions | 2018

Combined MitraClip Edge-to-Edge Repair With Millipede IRIS Mitral Annuloplasty

Jason H. Rogers; Walter D. Boyd; Thomas W. Smith; Adrian Ebner; Steven F. Bolling

Because multiple mechanistic etiologies of mitral regurgitation (MR) frequently coexist, there has been interest in combining or sequentially staging transcatheter approaches to eliminate MR. Combined therapies can be performed together at the time of initial treatment, or they can be staged for the


Catheterization and Cardiovascular Interventions | 2018

Usable implantation depth for watchman left atrial appendage occlusion is greater with appendage angiography than transesophageal echocardiography

Matthew S. Glassy; Gaurav Sharma; Gagan D. Singh; Thomas W. Smith; Dali Fan; Jason H. Rogers

To compare left atrial appendage (LAA) angiography to transesophageal echocardiography (TEE) for assessing usable LAA depth.


Catheterization and Cardiovascular Interventions | 2018

Initial clinical experience with the FlexPoint Steerable Transseptal Needle in left-sided structural heart procedures

Jason H. Rogers; Benjamin Stripe; Gagan D. Singh; Walter D. Boyd; Dali Fan; Thomas W. Smith

The purpose of this study is to describe the initial clinical experience with a steerable transseptal needle (STSN) for left‐sided structural heart procedures.


Archive | 2019

Transcatheter Management of Failed Mitral Valve Repair

Gagan D. Singh; Thomas W. Smith; Jason H. Rogers


Archive | 2019

Pearls From a Case of Left Atrial Appendage Closure

Jason H. Rogers; Gagan D. Singh; Thomas W. Smith


Archive | 2019

Occluder Therapy for Residual Mitral Regurgitation After Transcatheter Repair

Gagan D. Singh; Thomas W. Smith; Jason H. Rogers


Archive | 2019

Challenges of Transcatheter Therapy for Functional Mitral Regurgitation

Thomas W. Smith; Gagan D. Singh; Jason H. Rogers


Jacc-cardiovascular Interventions | 2018

CRT-700.59 Radiation Dose Reduction in Structural Heart Disease Interventions Using Noise Reduction Technology

Jeong Won Choi; Kwame Bodor-Tsia Atsina; Benjamin Stripe; Garrett B. Wong; Thomas W. Smith; Jason H. Rogers; Chin Shang Li; Gagan D. Singh; Walter Douglas Boyd; Paul A. Perry; Jeffrey A. Southard


Jacc-cardiovascular Interventions | 2018

CRT-700.29 Indexed Left Atrial Volume and 1-Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement

Jeong Won Choi; Kwame Bodor-Tsia Atsina; Benjamin Stripe; Matthew Lam; Jesse John Goitia; Pooja Prasad; Thomas W. Smith; Garrett B. Wong; Ching-Shang Li; Walter Douglas Boyd; Paul A. Perry; Jeffrey A. Southard

Collaboration


Dive into the Thomas W. Smith's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gagan D. Singh

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dali Fan

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul A. Perry

University of California

View shared research outputs
Top Co-Authors

Avatar

Walter D. Boyd

University of California

View shared research outputs
Top Co-Authors

Avatar

Adrian Ebner

University of California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge